• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别对以色列急性心肌梗死患者治疗管理的影响。以色列溶栓研究组。

Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. The Israeli Thrombolytic Survey Group.

作者信息

Behar S, Gottlieb S, Hod H, Narinsky R, Benari B, Rechavia E, Pauzner H, Rougin N, Kracoff O H, Katz A

机构信息

Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Israel.

出版信息

Am J Cardiol. 1994 Mar 1;73(7):438-43. doi: 10.1016/0002-9149(94)90672-6.

DOI:10.1016/0002-9149(94)90672-6
PMID:8141083
Abstract

A national study was performed in early 1992 in the 25 operating coronary care units in Israel, which enabled the assessment of whether the therapeutic management of patients with acute myocardial infarction was affected by patient gender. During a 2-month period, 1,014 consecutive patients with acute myocardial infarction were hospitalized. Thrombolytic therapy was given to 47% of men (362 of 769), and 43% of women (106 of 245) (p = NS). After adjustment for age, no gender differences in the administration of thrombolytic therapy were noted (odds ratio 0.95; 95% confidence interval 0.73-1.23). Coronary angiography was more frequently performed in men (22%) than in women (16%) (p < 0.05). However, no gender differences in the use of angioplasty or coronary bypass surgery performed during the index hospitalization were found (10% in men, and 8% in women). The main reasons for ineligibility for thrombolytic therapy were: late hospital arrival, absence of qualifying ST-T changes on admission electrocardiogram, and contraindications to thrombolytic therapy. Hospital death was significantly lower in patients receiving thrombolytic therapy (37 of 456; 8%) than in those excluded from thrombolysis (70 of 540;13%) (p < 0.01). This difference was significant for men, but not for women. The 1-year postdischarge mortality was 4% in patients treated compared with 12% in those ineligible for thrombolysis (p < 0.01). This significant difference persisted among men and women.

摘要

1992年初,以色列25个冠心病监护病房开展了一项全国性研究,该研究能够评估急性心肌梗死患者的治疗管理是否受患者性别的影响。在为期2个月的时间里,1014例急性心肌梗死患者连续入院。47%的男性(769例中的362例)和43%的女性(245例中的106例)接受了溶栓治疗(p =无显著性差异)。在对年龄进行调整后,未发现溶栓治疗的性别差异(优势比0.95;95%置信区间0.73 - 1.23)。男性接受冠状动脉造影的比例(22%)高于女性(16%)(p < 0.05)。然而,在本次住院期间进行血管成形术或冠状动脉搭桥手术的使用方面未发现性别差异(男性为10%,女性为8%)。不符合溶栓治疗条件的主要原因是:入院时间晚、入院心电图无符合条件的ST - T改变以及存在溶栓治疗的禁忌症。接受溶栓治疗的患者医院死亡率(456例中的37例;8%)显著低于未接受溶栓治疗的患者(540例中的70例;13%)(p < 0.01)。这种差异在男性中显著,但在女性中不显著。接受治疗的患者出院后1年死亡率为4%,而不符合溶栓条件的患者为12%(p < 0.01)。这种显著差异在男性和女性中均持续存在。

相似文献

1
Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. The Israeli Thrombolytic Survey Group.性别对以色列急性心肌梗死患者治疗管理的影响。以色列溶栓研究组。
Am J Cardiol. 1994 Mar 1;73(7):438-43. doi: 10.1016/0002-9149(94)90672-6.
2
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups.以色列冠心病监护病房中急性心肌梗死男性和女性的死亡率趋势。1981 - 1983年与1992 - 1994年的比较。为SPRINT和以色列溶栓研究组撰写。
Eur Heart J. 2000 Feb;21(4):284-95. doi: 10.1053/euhj.1999.1868.
3
[Use of thrombolysis for myocardial infarction in Israel].
Harefuah. 1992 Jun 15;122(12):753-6, 820.
4
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group.20世纪90年代急性心肌梗死后治疗及预后的性别差异:一项基于社区的前瞻性观察研究。以色列溶栓调查小组
Circulation. 2000 Nov 14;102(20):2484-90. doi: 10.1161/01.cir.102.20.2484.
5
Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.首次非Q波心肌梗死患者在再灌注时代前后的预后。SPRINT研究组和以色列溶栓研究组。以色列硝苯地平再梗死二级预防试验。
Am Heart J. 1998 Aug;136(2):245-51. doi: 10.1053/hj.1998.v136.90800.
6
The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Israeli Thrombolytic Survey Group.
Am J Med. 1996 Aug;101(2):184-91. doi: 10.1016/s0002-9343(96)80075-1.
7
Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel.以色列急性心肌梗死溶栓治疗的使用频率。
Am J Cardiol. 1991 Nov 15;68(13):1291-4. doi: 10.1016/0002-9149(91)90233-b.
8
Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry.急性心肌梗死治疗与预后的性别差异。心肌梗死分诊与干预登记研究结果。
Arch Intern Med. 1992 May;152(5):972-6.
9
Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007.2006 - 2007年治疗的急性心肌梗死在管理和预后方面的性别差异。
Cardiology. 2009;114(2):83-8. doi: 10.1159/000216582. Epub 2009 May 7.
10
On-site catheterization laboratory and prognosis after acute myocardial infarction. Israeli Thrombolytic Survey Group.急性心肌梗死后的现场导管实验室与预后。以色列溶栓研究小组。
Arch Intern Med. 1995 Apr 24;155(8):813-7.

引用本文的文献

1
Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review.急性心肌梗死患者院前延迟时间的年龄和性别差异:一项系统综述
Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):82-92. doi: 10.1161/CIRCOUTCOMES.109.884361. Epub 2009 Nov 24.
2
Influence of gender on treatment and short-term mortality of patients with acute myocardial infarction in Berlin.性别对柏林急性心肌梗死患者治疗及短期死亡率的影响
Z Kardiol. 2004 Dec;93(12):954-63. doi: 10.1007/s00392-004-0157-2.
3
Impact of selected geographical and clinical conditions on thrombolysis rate in myocardial infarction in three departments of France.
法国三个科室中选定的地理和临床条件对心肌梗死溶栓率的影响
Eur J Epidemiol. 2001;17(7):685-91. doi: 10.1023/a:1015514102907.
4
Do race and gender influence the use of invasive procedures?种族和性别会影响侵入性手术的使用吗?
J Gen Intern Med. 2001 Apr;16(4):227-34. doi: 10.1046/j.1525-1497.2001.016004227.x.
5
Saruplase is a safe and effective thrombolytic agent; observations in 1,698 patients: results of the PASS study. Practical Applications of Saruplase Study.
J Thromb Thrombolysis. 1999 Aug;8(2):143-50. doi: 10.1023/a:1008967219698.